Lydia S Lamb Hao-Wen Sim Ann I McCormack
10.3389/fendo.2020.576027
Front Endocrinol (Lausanne)
2020 Nov 18;11:576027.
aggressive pituitary tumors biomarker combination therapy immune checkpoint inhibitor immunotherapy pituitary carcinoma vascular endothelial growth factor inhibitor
CC BY
https://pubmed.ncbi.nlm.nih.gov/33312158/
Angiogenesis Inhibitors / therapeutic use Immune Checkpoint Inhibitors / therapeutic use Pituitary Neoplasms / drug therapy
Angiogenesis Inhibitors / therapeutic use Immune Checkpoint Inhibitors / therapeutic use Pituitary Neoplasms / drug therapy Case Reports Research Support, Non-U.S. Gov't Aged Drug Therapy, Combination ErbB Receptors / antagonists & inhibitors Female Humans Pituitary Neoplasms / pathology Prognosis Angiogenesis Inhibitors Immune Checkpoint Inhibitors EGFR protein, human ErbB Receptors
PMC7708326
33312158
Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy
2020